Top Markets
Coin of the day
Lobe Sciences Ltd. Lobe Sciences Ltd.

Lobe Sciences Ltd.

LOBE
Rang in aandelen #30765
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Aandeelprijs
$0.05504527
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$15.64M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
51.92%
Land
CA
Handel Lobe Sciences Ltd. (LOBE)

Categorie

Dividendrendementgeschiedenis voor Lobe Sciences Ltd. (LOBE)
Het dividendrendement (TTM) van Lobe Sciences Ltd. (aandelsymbool: LOBE) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Lobe Sciences Ltd. (LOBE) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten